D-dimer can predict survival in patients with chronic atrial fibrillation

被引:34
作者
Mahé, I
Drouet, L
Simoneau, G
Minh-Muzeaux, S
Caulin, C
Bergmann, JF
机构
[1] Lariboisiere Univ Hosp, Dept Internal Med, Paris, France
[2] Lariboisiere Univ Hosp, Dept Hematol, Paris, France
关键词
atrial fibrillation; D-dimer; death; thromboembolism;
D O I
10.1097/01.mbc.0000114440.81125.bd
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High mean levels of D-dimers (DD), markers of fibrin product and degradation, have been reported in patients with atrial fibrillation. In order to determine the predictive value of DD, 125 consecutive patients (mean age, 78 years) with chronic atrial fibrillation without acute disease were prospectively included. DD were quantified by Liatest at inclusion. Patients were followed for a mean duration of 2 years. DD and age at inclusion were significantly higher in patients who would die (n = 54) than in those who would not (n = 65). After multiple analysis of variance, age was not significantly related to prognosis (P = 0.36); low DID (P = 0.03) and oral anticoagulant therapy (P = 0.0192) were independently related to survival. In conclusion, a single determination of DD can strongly predict survival over the following 2 years. It may contribute to the risk stratification and perhaps to the choice of the antithrombotic therapy in high-risk patients with elevated DD. (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码:413 / 417
页数:5
相关论文
共 12 条
[1]   Antithrombotic therapy in atrial fibrillation [J].
Albers, GW ;
Dalen, JE ;
Laupacis, A ;
Manning, WJ ;
Petersen, P ;
Singer, DE .
CHEST, 2001, 119 (01) :194S-206S
[2]   Impact of atrial fibrillation on the risk of death [J].
Benjamin, EJ ;
Wolf, PA ;
D'Agostino, RB ;
Silbershatz, H ;
Kannel, WB ;
Levy, D .
CIRCULATION, 1998, 98 (10) :946-952
[3]   Study of cardiovascular risk factors and hemostatic molecular markers in elderly persons [J].
Deguchi, K ;
Deguchi, A ;
Wada, H ;
Murashima, S .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (01) :23-27
[4]  
Koenig W, 2003, THROMB HAEMOSTASIS, V89, P601
[5]   Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation [J].
Li-Saw-Hee, FL ;
Blann, AD ;
Lip, GYH .
STROKE, 2000, 31 (04) :828-833
[6]   Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation - Effects of introducing ultra-low-dose warfarin and aspirin [J].
Lip, GYH ;
Lip, PL ;
Zarifis, J ;
Watson, RDS ;
Bareford, D ;
Lowe, GDO ;
Beevers, DG .
CIRCULATION, 1996, 94 (03) :425-431
[7]   FIBRIN D-DIMER - A USEFUL CLINICAL MARKER OF THROMBOGENESIS [J].
LIP, GYH ;
LOWE, GDO .
CLINICAL SCIENCE, 1995, 89 (03) :205-214
[8]  
MacCallum PK, 2000, THROMB HAEMOSTASIS, V83, P421
[9]   D-dimer:: a characteristic of the coagulation state of each patient with chronic atrial fibrillation [J].
Mahé, I ;
Drouet, L ;
Chassany, O ;
Mazoyer, E ;
Simoneau, G ;
Knellwolf, AL ;
Caulin, C ;
Bergmann, JF .
THROMBOSIS RESEARCH, 2002, 107 (1-2) :1-6
[10]   Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation [J].
Roldán, V ;
Marín, F ;
Blann, AD ;
García, A ;
Marco, P ;
Sogorb, F ;
Lip, GYH .
EUROPEAN HEART JOURNAL, 2003, 24 (14) :1373-1380